J. Morganroth
Author detail
Bookitis has not yet captured a biography for this author, but the catalog links below show the books currently associated with this profile.
Overview
Catalog identity and bibliographic footprint for this author.
Catalog identity
How this author appears inside the active Bookitis catalog.
Display name
Source identifier
Featured books
Representative editions for works actually authored by this person.
- Image source: Open Library"A
"Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents"
cover - Image source: Open LibraryII
Interventions in the Acute Phase of Myocardial Infarction
cover - Image source: Open LibraryUA
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
cover - Image source: Open LibraryCA
Cardiac Arrhythmias : New Therapeutic Drugs and Devices
cover - Image source: Open LibrarySC
Sudden Cardiac Death and Congestive Heart Failure : Diagnosis and Treatment
cover - Image source: Open LibraryTE
The Evaluation of New Antiarrhythmic Drugs
cover - Image source: Open LibraryUA
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and ... & Devices, October 31 - November 1, 1989
cover - Image source: Open LibraryCH
Congestive heart failure
cover - RARisk/Benefit Analysis for the U...J. Morganroth
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
no cover - SMSilent Myocardial IschemiaJ. Morganroth
Silent Myocardial Ischemia
no cover - EOEvaluation of Beat Blocker and...J. Morganroth
Evaluation of Beat Blocker and Calcium Antagonist Drugs
no cover - CACardiac ArrhythmiasJ. Morganroth
Cardiac Arrhythmias
no cover
Works in catalog
Quick navigation into the work-level grouping pages behind the featured books.
- Open Work
"Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents"
- Open Work
Interventions in the Acute Phase of Myocardial Infarction
- Open Work
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
- Open Work
Cardiac Arrhythmias : New Therapeutic Drugs and Devices
- Open Work
Sudden Cardiac Death and Congestive Heart Failure : Diagnosis and Treatment
- Open Work
The Evaluation of New Antiarrhythmic Drugs
- Open Work
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and ... & Devices, October 31 - November 1, 1989
- Open Work
Congestive heart failure
- Open Work
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
- Open Work
Silent Myocardial Ischemia
- Open Work
Evaluation of Beat Blocker and Calcium Antagonist Drugs
- Open Work
Cardiac Arrhythmias